{"status":"OK","data":{"id":2841342,"identifier":"DVN/6U2KJ0","persistentUrl":"https://doi.org/10.7910/DVN/6U2KJ0","protocol":"doi","authority":"10.7910","publisher":"Harvard Dataverse","publicationDate":"2016-06-15","storageIdentifier":"s3://dvn-cloud:10.7910/DVN/6U2KJ0","latestVersion":{"id":84729,"storageIdentifier":"s3://dvn-cloud:10.7910/DVN/6U2KJ0","versionNumber":1,"versionMinorNumber":0,"versionState":"RELEASED","productionDate":"Production Date","UNF":"UNF:6:r+TeWLIEeSZqyLGyjiroaw==","lastUpdateTime":"2016-06-15T23:16:29Z","releaseTime":"2016-06-15T23:16:29Z","createTime":"2016-06-15T12:33:37Z","license":"CC0","termsOfUse":"CC0 Waiver","metadataBlocks":{"citation":{"displayName":"Citation Metadata","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"CD4 and ratio in GPA patients receiving rituximab"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"besada, emilio"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"UiT the Arctic University of Norway"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"besada, emilio"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"UiT the Arctic University of Norway"},"datasetContactEmail":{"typeName":"datasetContactEmail","multiple":false,"typeClass":"primitive","value":"emilio.besada@uit.no"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"CD4 and ratio in GPA patients receiving rituximab induction and maintenance. RTX induction was administered in 35 patients before June 2011.  "},"dsDescriptionDate":{"typeName":"dsDescriptionDate","multiple":false,"typeClass":"primitive","value":"2016-06-15"}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Medicine, Health and Life Sciences"]},{"typeName":"keyword","multiple":true,"typeClass":"compound","value":[{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"rituximab"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"anca-associated vasculitis"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"granulomatosis with polyangiitis"}}]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"besada, emilio"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2016-06-15"}]}},"files":[{"label":"CD4_study_PEERJ.tab","restricted":false,"version":2,"datasetVersionId":84729,"dataFile":{"id":2841343,"persistentId":"doi:10.7910/DVN/6U2KJ0/M2QMMH","pidURL":"https://doi.org/10.7910/DVN/6U2KJ0/M2QMMH","filename":"CD4_study_PEERJ.tab","contentType":"text/tab-separated-values","filesize":6471,"storageIdentifier":"s3://dvn-cloud:155540d51d2-eeaebfbaa13b","originalFileFormat":"application/x-spss-sav","originalFormatLabel":"SPSS SAV","UNF":"UNF:6:r+TeWLIEeSZqyLGyjiroaw==","rootDataFileId":-1,"md5":"71569e08545776738bafd2bdec476060","checksum":{"type":"MD5","value":"71569e08545776738bafd2bdec476060"}}}]}}}